Edward Hurwitz's Net Worth

$94 Million

Estimate Recalculated Jul 3, 2024 08:02PM EST

Who is Edward Hurwitz?

Edward Hurwitz has an estimated net worth of $94 Million. This is based on reported shares across multiple companies, which include COTHERIX INC, NeurogesX Inc, Cara Therapeutics, Inc., MACROGENICS INC, Dyne Therapeutics, Inc., APPLIED GENETIC TECHNOLOGIES CORP, THRESHOLD PHARMACEUTICALS INC, TURMERIC ACQUISITION CORP., SUNESIS PHARMACEUTICALS INC, TorreyPines Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..

SEC CIK

Edward Hurwitz's CIK is 0001211840

Past Insider Trading and Trends

2009 was Edward Hurwitz's most active year for acquiring shares with 14 total transactions. Edward Hurwitz's most active month to acquire stocks was the month of September. 2007 was Edward Hurwitz's most active year for disposing of shares, totalling 15 transactions. Edward Hurwitz's most active month to dispose stocks was the month of August. 2020 saw Edward Hurwitz paying a total of $9,249,999.59 for 11,651,284 shares, this is the most they've acquired in one year. In 2007 Edward Hurwitz cashed out on 29,052,604 shares for a total of $40,735,116.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COTHERIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.95M
$13.50
-$39,876,111.00
0
Jan 9
Form 4
-15.54%
-357.56K
—
—
1.94M
Nov 7
Form 4
-14.96%
-166.94K
$13.00
-$2,170,181.00
948.95K
Oct 14
Form 4
-18.14%
-247.31K
$13.00
-$3,215,082.00
1.12M
Oct 12
No matching records found

NeurogesX Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.74M
—
—
1.74M
May 7
Form 3
—
0
—
—
0
No matching records found

Cara Therapeutics, Inc. (CARA) Snapshot price: $0.5366

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.91M
$11.00
$1,240,987.00
1.91M
Feb 5
Form 4
—
0
—
—
0
Jan 30
Form 3
—
0
—
—
0
No matching records found

MACROGENICS INC (MGNX) Snapshot price: $17.425

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 21
Form 4
+13.61%
4.5K
—
—
37.57K
May 20
Form 4
+82.99%
15K
$4.91
$73,650.00
33.07K
Aug 30
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 20
Form 4
∞
18.07K
—
—
18.07K
May 11
Form 4
—
0
—
—
0
Jun 5
Form 4
-15.32%
-308.51K
$36.50
-$11,260,724.50
1.7M
Feb 18
Form 4
∞
2.01M
—
—
2.01M
Oct 16
Form 4
—
0
—
—
0
Oct 9
Form 3
—
0
—
—
0
No matching records found

Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.495

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 26
Form 4
∞
4.95M
—
—
4.95M
Jul 31 - Sep 21
Form 3
—
0
—
—
0
No matching records found